Triple-negative breast cancer (TNBC) characterized by the absence of estrogen receptor alpha (ER) and progesterone receptor (PR) expression and HER2 overexpression is mostly basal-like subgroup of breast cancers [1, 3] and accounts for 10%–20% of all breast cancers [4]. Here, ESR1 is linked to triple-negative breast carcinoma.